Skystar Bio-Pharmaceutical Announces $5 Million Registered Direct Offering – MarketWatch

Skystar Bio-Pharmaceutical Announces $5 Million Registered Direct Offering
MarketWatch
Pursuant to the terms of the agreement, the investor shall purchase from the Company 790,514 shares of common stock and warrants to purchase up to 197,629 shares of common stock for an aggregate purchase price of $4,000,000 and 1,000 shares of …

and more

…read more

Scroll to Top